169. メンケス病 Menkes disease Clinical trials / Disease details
臨床試験数 : 6 / 薬物数 : 6 - (DrugBank : 4) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 14
Showing 1 to 5 of 5 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04074512 (ClinicalTrials.gov) | October 15, 2019 | 27/8/2019 | Copper Histidinate Treatment for Menkes Disease | Copper Histidinate Treatment for Menkes Disease | Menkes Disease | Drug: Copper Histidinate | Cyprium Therapeutics, Inc. | NULL | Available | N/A | 6 Years | All | NULL | ||
2 | JPRN-UMIN000030626 | 2014/11/28 | 28/12/2017 | Investigation on the effectiveness of histidine copper treatment of Menkes disease patients | Investigation on the effectiveness of histidine copper treatment of Menkes disease patients - Investigation on the effectiveness of histidine copper treatment of Menkes disease patients Investigation on the effectiveness of histidinecopper treatment of Menkes disease patients - Investi ... | Menkes disease | Weekly,subcutaneous injection of histidine copper (750microgram once) is performed three times per week.It is continued every week until the end of the research during the research period. Weekly,subcutaneous injection of histidine copper(750microgram once) is performed three times per we ... | Hamamatsu University School of Medicine | NULL | Complete: follow-up complete | Not applicable | Not applicable | Male and Female | 2 | Not selected | Japan |
3 | JPRN-UMIN000005259 | 2011/03/03 | 18/03/2011 | Clinical trial of histidine-copper and diethyldithiocarbamate combination therapy for patients with Menkes disease Clinical trial of histidine-copper and diethyldithiocarbamate combination therapy for patients with ... | Clinical trial of histidine-copper and diethyldithiocarbamate combination therapy for patients with Menkes disease - Histidine-copper and diethyldithiocarbamate combination therapy for Menkes disease Clinical trial of histidine-copper and diethyldithiocarbamate combination therapy for patients with ... | Menkes disease | give a dose of copper-histidine and diethyldithiocarbamate | Kobe Unniversitu Graduate School of Medicine | NULL | Complete: follow-up complete | Not applicable | Not applicable | Male and Female | 2 | Not selected | Japan |
4 | NCT00811785 (ClinicalTrials.gov) | February 27, 2009 | 18/12/2008 | Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplain ... | Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplain ... | Menkes Disease;Occipital Horn Syndrome;Unexplained Copper Deficiency | Drug: Copper Histidine | Cyprium Therapeutics, Inc. | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);National Center for Complementary and Integrative Health (NCCIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);National Cen ... | Completed | N/A | 80 Years | All | 93 | Phase 3 | United States |
5 | NCT00001262 (ClinicalTrials.gov) | June 1990 | 3/11/1999 | Copper Histidine Therapy for Menkes Diseases | Early Copper Histidine Therapy in Menkes Disease | Kinky Hair Syndrome | Drug: Copper Histidine | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | NULL | Completed | N/A | N/A | All | 60 | Phase 1/Phase 2 | United States |